Could a common drug beat dialysis fatigue?
NCT ID NCT06609343
First seen Oct 31, 2025 · Last updated May 13, 2026 · Updated 27 times
Summary
This early-phase study tests whether bupropion, a drug used for smoking cessation and depression, can reduce severe fatigue in 16 adults with end-stage kidney disease on hemodialysis. Participants take the pill three times a week during dialysis for 8 weeks and report their fatigue levels. The goal is to find a safe, effective treatment for a symptom that currently has no medical management.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Dialysis Medical Center (DMC)
San Antonio, Texas, 78229, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.